1. Zhao Z, Leister WH, Robinson RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD, Huff JR, Huber HE, Duggan ME, Lindsley CW.. (2005) Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors., 15 (4): [PMID:15686884] [10.1016/j.bmcl.2004.12.062] |
2. Lindsley CW, Zhao Z, Leister WH, Robinson RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD, Huff JR, Huber HE, Duggan ME.. (2005) Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors., 15 (3): [PMID:15664853] [10.1016/j.bmcl.2004.11.011] |
3. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
4. Zhu, Gui-Dong GD and 19 more authors. 2006-07-01 Discovery and SAR of oxindole-pyridine-based protein kinase B/Akt inhibitors for treating cancers. [PMID:16644221] |
5. Heerding, Dirk A DA and 27 more authors. 2008-09-25 Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase. [PMID:18800763] |
6. Hall, Matthew D and 8 more authors. 2009-05-28 Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. [PMID:19397322] |
7. Okuzumi, Tatsuya and 6 more authors. 2009-07 Inhibitor hijacking of Akt activation. [PMID:19465931] |
8. McHardy, Tatiana and 17 more authors. 2010-03-11 Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt). [PMID:20151677] |
9. Blake, James F JF and 15 more authors. 2010-10-01 Discovery of pyrrolopyrimidine inhibitors of Akt. [PMID:20810279] |
10. Kim, Mi-hyun MH and 6 more authors. 2011-03-15 Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells. [PMID:21353571] |
11. Kim, Hyangmi; Kim, Minjung; Lee, Junghun; Yu, Hana and Hah, Jung-Mi. 2011-11-15 Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells. [PMID:22014755] |
12. Pireddu, Roberta and 10 more authors. 2012-06-01 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). [PMID:23275831] |
13. Addie, Matt M and 21 more authors. 2013-03-14 Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases. [PMID:23394218] |
14. Cheng, Hengmiao H and 12 more authors. 2013-05-01 Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series. [PMID:23506825] |
15. Brown, Andrew and 8 more authors. 2013-05-09 Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties. [PMID:23550937] |
16. Dumble, Melissa M and 13 more authors. 2014 Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor. [PMID:24978597] |
17. Ye, Qing Q and 14 more authors. 2015-03-01 Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents. [PMID:25662701] |
18. Lapierre, Jean-Marc JM and 19 more authors. 2016-07-14 Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor. [PMID:27305487] |
19. Sugimoto, Yasuro Y and 8 more authors. 2017-04-01 Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer. [PMID:28259529] |
20. Liu, Yang Y and 10 more authors. 2017-09-29 Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity. [PMID:28704757] |
21. Farag, Ahmed Karam AK and 5 more authors. 2017-12-01 Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders. [PMID:29107425] |
22. Klaeger, Susan S and 47 more authors. 2017-12-01 The target landscape of clinical kinase drugs. [PMID:29191878] |
23. Gao, Jun-Bo JB and 8 more authors. 2018-04-27 Isolation, Characterization, and Structure-Activity Relationship Analysis of Abietane Diterpenoids from Callicarpa bodinieri as Spleen Tyrosine Kinase Inhibitors. [PMID:29578342] |
24. Zhang, Daoguang D and 5 more authors. 2018-08-01 Design, synthesis and biological evaluation of AKT inhibitors bearing a piperidin-4-yl appendant. [PMID:30151089] |
25. Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048] |
26. Zha, Gao-Feng; Rakesh, K P; Manukumar, H M; Shantharam, C S and Long, Sihui. 2019-01-15 Pharmaceutical significance of azepane based motifs for drug discovery: A critical review. [PMID:30469042] |
27. Zhan, Wenhu W and 9 more authors. 2019-07-07 Discovery of pyrazole-thiophene derivatives as highly Potent, orally active Akt inhibitors. [PMID:31301565] |
28. Kumar, Jetta Sandeep and 12 more authors. 2020-09-01 Rosuvastatin based novel 3-substituted isocoumarins / 3-alkylidenephthalides: Ultrasound assisted synthesis and identification of new anticancer agents. [PMID:32599323] |